Letter to FDA Commissioner Hamburg on FDA Advisory Committee Chair Participation in Pharmaceutical Industry Conference
October 24, 2013
View letter, conference brochure and CV here.
View Press Release.
In a letter to Food and Drug Administration (FDA) Commissioner Margaret Hamburg, Public Citizen’s Dr. Sidney Wolfe raises concerns regarding the participation of an FDA Advisory Committee chairperson in a pharmaceutical industry conference. In her conference presentation, the chairperson will be advising industry employees on ways to improve the likelihood of a drug’s receiving FDA approval. Such pro-industry activity on the part of an advisory committee representative could undermine public confidence both in FDA advisory committees and in the agency itself.